✦ LIBER ✦

HPV16 and increased risk of recurrence after treatment for CIN

✍ Scribed by Murat Gök; Veerle M.H. Coupé; Johannes Berkhof; René H.M. Verheijen; Theo J.M. Helmerhorst; Cornelis J.A. Hogewoning; Peter J.F. Snijders; Chris J.L.M. Meijer

Book ID: 113960864
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 122 KB
Volume: 104
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2006.10.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HPV16 and increased risk of recurrence a

HPV16 and increased risk of recurrence after treatment for CIN

✍ Hasan Kafali 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Reply to HPV16 and increased risk of rec

Reply to HPV16 and increased risk of recurrence after treatment for CIN

✍ Chris J. Meijer; M. Gök; R.H. Verheijen 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Recurrent hepatocellular carcinoma has a

Recurrent hepatocellular carcinoma has an increased risk of subsequent recurrence after curative treatment

✍ Noriyo Yamashiki; Haruhiko Yoshida; Ryosuke Tateishi; Shuichiro Shiina; Takuma T 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

Pre- and post-conization high-risk HPV t

Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2–3

✍ Immaculada Alonso; Aureli Torné; Luis M. Puig-Tintoré; Roser Esteve; Llorenç Qui 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Obstetric management of women after trea

Obstetric management of women after treatment for CIN

✍ S Quenby 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Disappearance of antibodies to HPV 16 E7

Disappearance of antibodies to HPV 16 E7 after treatment for cervical cancer

✍ Joakim Dillner 📂 Article 📅 1993 🏛 The Lancet 🌐 English ⚖ 167 KB